JP2024519188A5 - - Google Patents

Info

Publication number
JP2024519188A5
JP2024519188A5 JP2024515728A JP2024515728A JP2024519188A5 JP 2024519188 A5 JP2024519188 A5 JP 2024519188A5 JP 2024515728 A JP2024515728 A JP 2024515728A JP 2024515728 A JP2024515728 A JP 2024515728A JP 2024519188 A5 JP2024519188 A5 JP 2024519188A5
Authority
JP
Japan
Application number
JP2024515728A
Other languages
Japanese (ja)
Other versions
JPWO2022247816A5 (https=
JP2024519188A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2022/094612 external-priority patent/WO2022247816A1/zh
Publication of JP2024519188A publication Critical patent/JP2024519188A/ja
Publication of JP2024519188A5 publication Critical patent/JP2024519188A5/ja
Publication of JPWO2022247816A5 publication Critical patent/JPWO2022247816A5/ja
Pending legal-status Critical Current

Links

JP2024515728A 2021-05-24 2022-05-24 含窒素複素環系化合物、その調製方法及びその医薬的応用 Pending JP2024519188A (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
CN202110565410.0 2021-05-24
CN202110565410 2021-05-24
CN202110694022 2021-06-22
CN202110694022.2 2021-06-22
CN202110856289 2021-07-28
CN202110856289.7 2021-07-28
CN202210198679 2022-03-02
CN202210198679.4 2022-03-02
PCT/CN2022/094612 WO2022247816A1 (zh) 2021-05-24 2022-05-24 含氮杂环类化合物、其制备方法及其在医药上的应用

Publications (3)

Publication Number Publication Date
JP2024519188A JP2024519188A (ja) 2024-05-08
JP2024519188A5 true JP2024519188A5 (https=) 2025-06-03
JPWO2022247816A5 JPWO2022247816A5 (https=) 2025-06-03

Family

ID=84229501

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024515728A Pending JP2024519188A (ja) 2021-05-24 2022-05-24 含窒素複素環系化合物、その調製方法及びその医薬的応用

Country Status (11)

Country Link
US (1) US20240287094A1 (https=)
EP (1) EP4349836A4 (https=)
JP (1) JP2024519188A (https=)
KR (1) KR20240012437A (https=)
CN (1) CN117177971A (https=)
AU (1) AU2022280845A1 (https=)
BR (1) BR112023022496A2 (https=)
CA (1) CA3219858A1 (https=)
MX (1) MX2023013890A (https=)
TW (1) TW202313630A (https=)
WO (1) WO2022247816A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230159525A1 (en) 2021-10-01 2023-05-25 Xinthera, Inc. Azetidine and pyrrolidine parp1 inhibitors and uses thereof
AU2023209820B2 (en) 2022-01-21 2024-10-10 Xinthera, Inc. Parp1 inhibitors and uses thereof
KR20240161147A (ko) 2022-03-14 2024-11-12 슬랩 파마슈티컬스 엘엘씨 다중 사이클릭 화합물
FI4497438T3 (fi) 2022-04-28 2025-10-20 Xinthera Inc Trisyklisiä parp1:n estäjiä ja niiden käyttötapoja
WO2024041643A1 (zh) * 2022-08-25 2024-02-29 江苏恒瑞医药股份有限公司 稠合三环类化合物、其制备方法及其在医药上的应用
CN120035596A (zh) * 2022-11-23 2025-05-23 江苏恒瑞医药股份有限公司 一种含氮杂环类化合物的可药用盐、晶型及制备方法
AU2024286996A1 (en) 2023-06-08 2026-01-08 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Preparation method for formamide compounds
CN120677162A (zh) * 2023-06-13 2025-09-19 中国医药研究开发中心有限公司 含氮杂环类化合物及其医药用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4138564A (en) 1977-08-03 1979-02-06 American Home Products Corporation Tetrahydro[1H]pyrazino[1,2-a]azaquinoxalin-5(6H)-ones and derivatives thereof
AUPS137402A0 (en) * 2002-03-26 2002-05-09 Fujisawa Pharmaceutical Co., Ltd. Novel tricyclic compounds
US8299256B2 (en) 2007-03-08 2012-10-30 Janssen Pharmaceutica Nv Quinolinone derivatives as PARP and TANK inhibitors
US8404713B2 (en) 2007-10-26 2013-03-26 Janssen Pharmaceutica Nv Quinolinone derivatives as PARP inhibitors
CN102372716A (zh) * 2010-08-09 2012-03-14 江苏恒瑞医药股份有限公司 酞嗪酮类衍生物、其制备方法及其在医药上的应用
TWI693218B (zh) 2014-11-14 2020-05-11 美商美國禮來大藥廠 極光a激酶抑制劑
JP7469304B2 (ja) * 2018-11-16 2024-04-16 江▲蘇▼恒瑞医▲薬▼股▲フン▼有限公司 Parpインヒビタを含む医薬組成物
MX2022000711A (es) * 2019-07-19 2022-02-23 Astrazeneca Ab Inhibidores de parp1.
CN116018132A (zh) 2020-06-24 2023-04-25 Itf研究制药有限公司 软明胶胶囊
US11795158B2 (en) 2020-06-25 2023-10-24 Astrazeneca Ab Chemical compounds
TW202309025A (zh) * 2021-04-19 2023-03-01 美商辛瑟拉股份有限公司 Parp1抑制劑及其用途
CN119110801A (zh) * 2022-05-07 2024-12-10 南京明德新药研发有限公司 选择性抑制parp1的氟代喹喔啉酮衍生物

Similar Documents

Publication Publication Date Title
CL2025004020A1 (es) Vehículo sumergible.
CL2025003847A1 (es) Composiciones adyuvantes en nanoemulsión para vacunas contra el papilomavirus humano.
CL2025003402A1 (es) Aplicador agrícola.
BR102023014872A2 (https=)
BR102023012440A2 (https=)
BR102023009641A2 (https=)
BR102023008688A2 (https=)
BR102023007252A2 (https=)
BR102023005164A2 (https=)
BR102023001877A2 (https=)
BR102023000289A2 (https=)
BR102022026909A2 (https=)
BR102022023461A2 (https=)
BR202022009269U2 (https=)
BR202022005961U2 (https=)
BR202022001779U2 (https=)
BR202022000931U2 (https=)
BY13145U (https=)
BY13160U (https=)
BY13141U (https=)
BY13142U (https=)
BY13143U (https=)
BY13144U (https=)
BY13137U (https=)
BY13135U (https=)